Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Latest filing published 11 Feb 2025 for Marinus Pharmaceuticals, INC., €4,554. Read the official filing
Filing timeline
BuySaleElan Ezickson
Insider track record
Disclosed buys
0
Disclosed sells
2
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Elan Ezickson: trading record in brief
Elan Ezickson discloses dealings in Marinus Pharmaceuticals, Inc. to SEC (Form 4). In total, 7 filings cover trades dated from 4 February 2022 to 7 February 2025.
Sales make up the whole of the open-market record (2 sales, €5,389). The rest of the record consists of 4 share grants. 2025 to date brings no purchases and 1 sale.
The latest filing, published on 11 February 2025, reports a transaction of €4,554 in Marinus Pharmaceuticals, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Elan Ezickson
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations7 total
8,600 shares@ US$0.5545.8% of flowCommon StockSEC:0001104659-25-011248:0
1,600 shares@ US$0.548.3% of flowCommon StockSEC:0001415889-25-001930:0
2,300 shares0Common StockSEC:0001415889-24-017634:0
4,600 shares0Common StockSEC:0001415889-24-001600:0
750 shares@ US$6.5645.9% of flowCommon StockSEC:0001415889-23-002162:0
3,600 shares0Common StockSEC:0001415889-23-001560:0
2,750 shares0Common StockSEC:0001104659-22-012783:0
7 of 7 declarations
